Drug
Antibodies clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2004 (3)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 5
St. Jude Children's Research Hospital (4) · Memorial Sloan Kettering Cancer Center (1)
Related medicines
As reviewed, each with the page that says it.
- One of Immunologic Factors source
Studies
Open first, then newest update. How each study uses Antibodies is read from its arms, and is right about nine times in ten.
Testing it · 5
- Safety Study of Radio-labeled huA33 Antibody in Colorectal CancerCompletedNot applicableMemorial Sloan Kettering Cancer CenterNCT00199862Written as Iodine-124 labeled humanized A33 (antibody)
- HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic MalignanciesCompletedPhase 2St. Jude Children's Research HospitalNCT00145626Written as Chemotherapy and antibodies
- Stem Cell Transplantation for Children Affected With OsteopetrosisTerminatedNot applicableSt. Jude Children's Research HospitalNCT00145587Written as Systemic chemotherapy and antibodies
- Haploidentical Stem Cell Transplant for Treatment Refractory Hematological MalignanciesCompletedPhase 2St. Jude Children's Research HospitalNCT00145613Written as Systemic chemotherapy and antibodies
- Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedPhase 3St. Jude Children's Research HospitalNCT00152139Written as Chemotherapy and antibodies
Codes
What other systems call Antibodies · ClinicalTrials.gg INT006992
- MeSH (NLM) D000906AntibodiesOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000906 | Antibodies | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.